The market wrapped up a record-breaking year with losses as major indexes closed lower, despite strong annual gains driven by tech and economic growth.
New Medicare drug price cap starts January 1, 2025, limiting out-of-pocket costs to $2,000 annually for beneficiaries under the Inflation Reduction Act.
Putin reassures Russians in New Year speech, despite ongoing war in Ukraine and economic challenges, emphasizing national pride without clear direction.
IRS funding reduced by $20 billion impacts tax audits for high-earners, risking an increase in national debt and potential tax burdens for average earners.